Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603

Watchlist Manager
Shijiazhuang Yiling Pharmaceutical Co Ltd Logo
Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
Watchlist
Price: 16.83 CNY -3.99% Market Closed
Market Cap: 28.1B CNY
Have any thoughts about
Shijiazhuang Yiling Pharmaceutical Co Ltd?
Write Note

Shijiazhuang Yiling Pharmaceutical Co Ltd
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shijiazhuang Yiling Pharmaceutical Co Ltd
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
Common Shares Outstanding
ÂĄ1.7B
CAGR 3-Years
0%
CAGR 5-Years
7%
CAGR 10-Years
4%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Common Shares Outstanding
ÂĄ5.9B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Common Shares Outstanding
ÂĄ603.3m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Common Shares Outstanding
ÂĄ6.4B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Common Shares Outstanding
ÂĄ1.8B
CAGR 3-Years
0%
CAGR 5-Years
11%
CAGR 10-Years
6%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Common Shares Outstanding
ÂĄ401m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shijiazhuang Yiling Pharmaceutical Co Ltd
Glance View

Market Cap
28.1B CNY
Industry
Pharmaceuticals

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the pharmaceutical manufacturing. The company is headquartered in Shijiazhuang, Hebei and currently employs 15,155 full-time employees. The company went IPO on 2011-07-28. The firm mainly provides cardiovascular and cerebrovascular drugs and anti-cold drugs. The firm also provides food and beverage products. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
20.09 CNY
Undervaluation 16%
Intrinsic Value
Price

See Also

What is Shijiazhuang Yiling Pharmaceutical Co Ltd's Common Shares Outstanding?
Common Shares Outstanding
1.7B CNY

Based on the financial report for Sep 30, 2024, Shijiazhuang Yiling Pharmaceutical Co Ltd's Common Shares Outstanding amounts to 1.7B CNY.

What is Shijiazhuang Yiling Pharmaceutical Co Ltd's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
4%

Over the last year, the Common Shares Outstanding growth was 0%.

Back to Top